Viewing nowCombinationEscarb Tablets 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202300055 · Approved 2023.01.05 · Insurance code 657308780
Improvement of blood pressure control in essential hypertension
Pimasartan potassium is used to lower blood pressure, but additional treatment may be needed for patients with essential hypertension who do not achieve sufficient blood pressure control on monotherapy. In such cases, blood pressure can be managed more effectively by combining it with other medications. Therefore, Pimasartan potassium is used to improve blood pressure control in essential hypertension.
The recommended dose for adults is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). If blood pressure is not controlled with Pimasartan 30 mg or 60 mg monotherapy, a switch to this product in dosages of 30/2.5 mg or 60/2.5 mg may be considered. For patients whose blood pressure is not adequately controlled with Pimasartan 60 mg monotherapy or this medication at 60/2.5 mg, a switch to Pimasartan at 60/5 mg may be considered.
Safety and efficacy in pediatric and adolescent patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication's active substance or related components, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with moderate to severe liver impairment, patients with biliary obstruction, patients with certain diabetes and kidney diseases should not take this medication. Patients with low blood volume or salt, patients with impaired kidney function, patients with renovascular hypertension, patients with heart valve disease, patients with severe hypotension, elderly individuals, and others should exercise special caution when using this medication. This medication may cause side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing, and in rare cases, serious adverse reactions have been reported, so medical consultation should be sought immediately if any unusual symptoms occur. This medication lowers blood pressure, so patients with hypotension or electrolyte imbalances should correct their condition before taking it and monitor their condition closely during treatment. Additionally, due to the risk of hyperkalemia, it is recommended to periodically check serum potassium levels. This medication may interact with other antihypertensive agents, diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so if you are taking other medications, be sure to inform your healthcare provider. Pregnant women or those planning to become pregnant should avoid taking this medication, and women who are breastfeeding should preferably stop breastfeeding or discontinue this medication while taking it. Safety and efficacy in children and adolescents under 18 years of age have not been established. No special dosage adjustment is needed for elderly patients; however, some elderly individuals may be more sensitive to this medication, so caution is required. Patients with moderate to severe liver impairment should not take this medication. In case of overdose, symptoms such as hypotension, palpitations, and reflex tachycardia may occur; in such cases, immediate medical attention should be sought. This medication should be kept out of reach of children, and transferring to another container may compromise the quality, so care should be taken.
Urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mouth/eye mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory disturbances accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness over time.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.